X

Please update your browser.

For the best experience, we recommend that you use the latest version of Chrome, Internet Explorer, or Firefox.

Buyouts Magazine: Co-Investment Advantages Boost Investor Interest

Co-investments can add incremental, tactical private equity exposure for a typically lower all-in cost, say David Brett, Michael Taylor and Craig ...

Buyout Managers Can’t Lean on Leverage Amid Higher Rates, Slower Growth

As interest rates rise and growth slows, buyout managers who rely on leverage to generate returns are likely to underperform those with deep secto ...

Bank Instability – Important Considerations for Private Equity Investors

Jeff Diehl, Adams Street’s Managing Partner & Head of Investments, shares observations and important considerations for private markets inves ...

It’s a Case of ‘BuyIRR Beware’ for Private Equity Investors as Headwinds Compress Multiples

“BuyIRR Beware” is the mantra we believe investors need to heed when selecting private equity managers. The ability to distinguish between repeata ...

Powerful Long-Term Trends Boost Venture Capital Outlook

Venture capital firms have a multi-decade history of facilitating innovation. Recent valuation corrections add to the venture opportunity, which w ...

PEI Keynote Interview: Fertile Ground for Growth Equity

Private Equity International recently spoke with Robin Murray, Tom Bremner, and Fred Wang to discuss the outlook on growth capital investing.

Buyouts Magazine: From Upstarts to Titans

Buyouts spoke with Sunil Mishra, Sergey Sheshuryak, and James Korczak to discuss why emerging managers can provide an edge in pursuing niche, over ...

Innovative Startups Advance Health Outcomes for Women

Innovative growth-stage companies in the $4.3 trillion US healthcare market are introducing potentially transformative approaches that cater to th ...

Growth Equity Market Appears Primed to Shine, But Beware of Slippery Rocks

Technological innovation and excess demand for capital augur well for growth equity managers with strong records in their discipline and a focus o ...

Funding Imbalance, Thriving Innovation Boost Growth Equity Outlook

Many growth stage companies that delayed fundraising in 2022 as valuations dipped will likely have to seek additional capital by the end of 2023, ...

AI Holds Promise to Drive Standards of Care, Cut Healthcare Waste

From automating drug discovery and speeding up clinical decision making to reducing administration and improving record keeping, AI applications h ...

AI – A Venture Investment Opportunity That is Hard to Ignore

Generative AI is a transformative technology that holds the promise to fundamentally change how we learn, create, work, and live by accelerating o ...

Why We Invested in Turquoise Health – Eliminating the Financial Complexity of Healthcare

Turquoise’s software streamlines transparent pricing workflows for healthcare organizations, while clarifying costs for patients.

Why We Invested in Glean – Empowering Enterprise AI Productivity

Glean’s fusion of enterprise search and generative AI helps usher in a new era of employee productivity.

Navigating Private Markets in 2024: Opportunity Knocks as Change Accelerates

Our fourth annual Global Investor Survey points to increasing optimism among private markets investors about the outlook for fundraising, liquidit ...